ATROFIA MUSCULAR ESPINAL: MANEJO RESPIRATORIO EN LA PERSPECTIVA DE LOS RECIENTES AVANCES TERAPÉUTICOS

Mercuri, 2012, Childhood spinal muscular atrophy: controversies and challenges, Lancet Neurol, 11, 10.1016/S1474-4422(12)70061-3 Castiglioni, 2008, Avances en el diagnóstico y manejo de las enfermedades neuromusculares, REV. MED. CLIN. CONDES -, 19, 536 Castiglioni, 2011, Atrofia muscular espinal: Caracterización clínica, electrofisiológica y molecular de 26 pacientes, Rev Med Chile, 139, 197, 10.4067/S0034-98872011000200009 Bladen, 2014, et col. Mapping the differences in care for 5, 000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe, J Neurol., 261, 10.1007/s00415-013-7154-1 Wang CH1, 2007, Standard of Care. Consensus statement for standard of care in spinal muscular atrophy, J Child Neurol., 22 Sansone, 2015, 1st Italian SMA Family Association Consensus Meeting:, Neuromuscular Disorders, 979 Oskoui, 2007, The changing natural history of spinal muscular atrophy type 1, Neurology., 69, 10.1212/01.wnl.0000290830.40544.b9 Faravelli, 2015, Spinal muscla atrophy, recente therapeutic advances for an old challenge, Nat Rev Neurol., 10.1038/nrneurol.2015.77 Chirimoya, 2016, Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy, Neurology, 86 Ching, 2003, Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III, J Paediatr Child Health., 39 Bersanini, 2012, Nocturnal hypoxaemia and hypercapnia in children with neuromuscular disorders, Eur Respir J, 39, 10.1183/09031936.00087511 Swoboda, 2005, Natural history of denervation in SMA: relation to age, SMN2 copy number, and function, Ann Neurol, 57, 10.1002/ana.20473 Torres-Castro, 2014, Estrategias terapeuticas para aumentar la eficacia de la tos en pacientes con enfermedades neuromusculares, Rev Med Chil, 142, 10.4067/S0034-98872014000200013 Bianchi, 2008, Cough peak flows: standard values for children and adolescents, Am J Phys Med Rehabil, 87, 10.1097/PHM.0b013e318174e4c7 Aguerre, 2014, Consenso de cuidados respiratorios en enfermedades neuromusculares en ninos: resumen ejecutivo, Arch Argent Pediatr, 112 Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012; 67(i):1-40 Society BT. Guidelines for respiratory management of children with neuromuscular weakness. Thorax. 2012 Julio; 67.(1). Martínez-Llores, 2011, Presión inspiratoria nasal: ¿una alternativa para la evaluación de la fuerza muscular inspiratoria?, Arch Bronconeumol, 47 Marques, 2014, Air stacking: effects on pulmonary function in patients with spinal muscular atrophy and in patients with congenital muscular dystrophy, Jornal Brasileiro de Pneumologia., 40, 528, 10.1590/S1806-37132014000500009 Chatwin, 2008, How to use a mechanical insufflator-exsufflator ‘cough assist machine’, Breathe., 4 Nygren-Bonnier, 2009, Glossopharyngeal pistoning for lung insufflation in children with spinal muscular atrophy type II, Acta Paediatr, 98, 1324, 10.1111/j.1651-2227.2009.01343.x Chatwin, 2011, Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type I, Arch Dis Child, 96, 10.1136/adc.2009.177832 2009, Initiating Noninvasive Management of Respiratory Insufficiency in Neuromuscular Disease Joshua O. Benditt,MD, Pediatrics, 123 Prado, 2008, Asistencia ventilatoria no invasiva en pediatría, Rev Chil Pediatr, 79, 580, 10.4067/S0370-41062008000600002 2003, Treatment of nocturnal sleep disturbance can result in improved quality of life, reduced daytime hypercarbia, and increased survival rates.3. Simonds AK. Home ventilation, Eur Respir J. Suppl., 47 Petrone A1, 2007, Noninvasive ventilation in children with spinal muscular atrophy types 1 and 2, Am J Phys Med Rehabil., 86, 10.1097/PHM.0b013e31802ef774 Zerres, 1995, Natural history in proximal spinal muscular atrophy, Arch Neurol., 52, 10.1001/archneur.1995.00540290108025 Bach, 2003, Prevention of precuts excavated for children with spinal muscular atrophy type I, Am J Phys Med Rehabil, 82, 815, 10.1097/01.PHM.0000083669.22483.04 Tassie, 2013, Management of children with spinal muscular atrophy type 1 in Australia, J. Paediatr. Child Health, 49, 10.1111/jpc.12291 Bush, 2005, Respiratory management of the infant with type 1 spinal muscular atrophy, Arch Dis Child, 90, 10.1136/adc.2004.065961 Bach, 2008, The use of mechanical ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion for, Pediatric Respiratory Reviews, 9, 45, 10.1016/j.prrv.2007.11.003 Ryan, 2008, The use of invasive ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion against, Paaediatric Respiratory Reviews, 9, 51, 10.1016/j.prrv.2007.10.002 Chatwin, 2011, Outcome of goal-directed non-invasive ventilation and in spinal muscular atrophy type I, Arch Dis Child., 96, 10.1136/adc.2009.177832 Bach, 2012, Changing Trends in the Management of End-Stage Neuromuscular Respiratory Muscle Failure. Recommendations of an International Consensus, Am J Phys Med Rehabil, 91, 1 Bach, 2000, Spinal muscular atrophy type I: a non invasive respiratory approach, Chest, 117, 1100, 10.1378/chest.117.4.1100 Bach, 2003, Spinal muscular atrophy type 1 quality of life, Am J Phys Med Rehabil, 82, 10.1097/00002060-200302000-00009 Ryan, 2007, Spinal muscular atrophy type 1: is long-term mechanical ventilation ethical?, J. Paediatr. Child Health, 43, 10.1111/j.1440-1754.2007.01052.x Lillo, 2014, El proceso de comunicar y acompañar a los padres y al paciente frente al diagnóstico de, discapacidad, REV. MED. CLIN. CONDES, 25, 372 Simonds, 2005, Ethical aspects of home long term ventilation in children with neuromuscular disease, Paediatr Respir Rev., 6, 10.1016/j.prrv.2005.06.003 Bach, 2007, Long-Term Survival in Werdnig– Hoffmann Disease, Am. J. Phys. Med. Rehabil., 86 Schroth, 2009, Special Considerations in the Respiratory Management of Spinal Muscular Atrophy, Pediatrics, 123, 10.1542/peds.2008-2952K Gregoretti, 2013, Survival of Patients With Spinal Muscular Atrophy Type 1, Pediatrics., 131 Sivanesan s, 2013, Antisense oligonucleotide mediated therapy of spinal muscular atrophy, Trails Neurosci, 4, 1, 10.2478/s13380-013-0109-2 2014